DK1479394T3 - Anvendelse af epidermal vækstfaktor (EGF) til ögning af vækstforögelse hos et dyr - Google Patents

Anvendelse af epidermal vækstfaktor (EGF) til ögning af vækstforögelse hos et dyr

Info

Publication number
DK1479394T3
DK1479394T3 DK04019831T DK04019831T DK1479394T3 DK 1479394 T3 DK1479394 T3 DK 1479394T3 DK 04019831 T DK04019831 T DK 04019831T DK 04019831 T DK04019831 T DK 04019831T DK 1479394 T3 DK1479394 T3 DK 1479394T3
Authority
DK
Denmark
Prior art keywords
egf
animal
growth factor
increase
epidermal growth
Prior art date
Application number
DK04019831T
Other languages
English (en)
Inventor
Andre G Buret
D Grant Gall
James A Hardin
Merle E Olson
Original Assignee
Univ Technologies Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Technologies Int filed Critical Univ Technologies Int
Application granted granted Critical
Publication of DK1479394T3 publication Critical patent/DK1479394T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • A61K31/277Nitriles; Isonitriles having a ring, e.g. verapamil
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/142Amino acids; Derivatives thereof
    • A23K20/147Polymeric derivatives, e.g. peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/168Steroids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/184Hormones
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/30Feeding-stuffs specially adapted for particular animals for swines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1808Epidermal growth factor [EGF] urogastrone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK04019831T 1995-05-10 1996-05-09 Anvendelse af epidermal vækstfaktor (EGF) til ögning af vækstforögelse hos et dyr DK1479394T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/438,901 US5753622A (en) 1995-05-10 1995-05-10 Use of epidermal growth factor as a gastrointestinal therapeutic agent
PCT/CA1996/000291 WO1996035445A1 (en) 1995-05-10 1996-05-09 The use of epidermal growth factor as a gastrointestinal therapeutic agent

Publications (1)

Publication Number Publication Date
DK1479394T3 true DK1479394T3 (da) 2007-06-11

Family

ID=23742496

Family Applications (3)

Application Number Title Priority Date Filing Date
DK96913397T DK0824357T3 (da) 1995-05-10 1996-05-09 Anvendelsen af epidermal vækstfaktor som et gastrointestinalt terapeutisk middel
DK00123426T DK1092437T3 (da) 1995-05-10 1996-05-09 Anvendelse af epidermal vækstfaktor som et gastrointestinalt terapeutisk middel
DK04019831T DK1479394T3 (da) 1995-05-10 1996-05-09 Anvendelse af epidermal vækstfaktor (EGF) til ögning af vækstforögelse hos et dyr

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DK96913397T DK0824357T3 (da) 1995-05-10 1996-05-09 Anvendelsen af epidermal vækstfaktor som et gastrointestinalt terapeutisk middel
DK00123426T DK1092437T3 (da) 1995-05-10 1996-05-09 Anvendelse af epidermal vækstfaktor som et gastrointestinalt terapeutisk middel

Country Status (12)

Country Link
US (2) US5753622A (da)
EP (3) EP1479394B1 (da)
JP (1) JP3549541B2 (da)
AT (3) ATE278415T1 (da)
AU (1) AU704675B2 (da)
CA (2) CA2220434C (da)
DE (3) DE69614377T2 (da)
DK (3) DK0824357T3 (da)
ES (2) ES2226681T3 (da)
NZ (2) NZ307134A (da)
PT (1) PT1479394E (da)
WO (1) WO1996035445A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753622A (en) * 1995-05-10 1998-05-19 University Technologies International, Inc. Use of epidermal growth factor as a gastrointestinal therapeutic agent
US5929051A (en) * 1998-05-13 1999-07-27 Carrington Laboratories, Inc. Aloe pectins
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
US6313103B1 (en) 1998-05-13 2001-11-06 Carrington Laboratories, Inc. Pectic substance as a growth factor stabilizer
US20060014684A1 (en) * 2000-03-03 2006-01-19 University Technologies International Inc. Novel uses of EGF
US7494669B2 (en) 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
JP2004536589A (ja) * 2001-05-18 2004-12-09 カナダ国 ウシ上皮成長因子の核酸及びタンパク質配列
CA2464609A1 (en) * 2001-10-26 2003-05-01 University Technologies International, Inc. Use of egf to inhibit pathogenic infections of the urogenital tract
CA2427190A1 (en) * 2002-04-30 2003-10-30 Alberta Research Council Inc. Production of recombinant epidermal growth factor in plants
JP2005529622A (ja) 2002-06-19 2005-10-06 ヴェーイーベー・ヴェーゼットウェー 腸吸収を促進するための方法および手段
JP2008514651A (ja) * 2004-09-30 2008-05-08 ユニバーシティー・テクノロジーズ・インターナショナル・インコーポレイテッド 上皮増殖因子(egf)を含んで成る再水和組成物
US8703769B2 (en) * 2005-07-15 2014-04-22 The University Of North Carolina At Chapel Hill Use of EGFR inhibitors to prevent or treat obesity
ES2405552T3 (es) 2005-11-29 2013-05-31 Actogenix N.V. Inducción de tolerancia mucosa a antiantígenos de células beta de islotes pancreáticos
WO2008090223A2 (en) 2007-01-25 2008-07-31 Actogenix N.V. Treatment of immune disease by mucosal delivery of antigens using genetically modified lactobacillus
US20110275566A1 (en) * 2008-10-10 2011-11-10 Nationwide Children's Hospital Inc. Methods of treating necrotizing enterocolitis using heparin binding epidermal growth factor (hb-egf)
CN102696887B (zh) * 2012-06-20 2013-07-31 湖南海谷生物技术有限公司 一种具有营养保健促生长功能的饲料活性蛋粉及其生产方法
US11241480B2 (en) * 2017-01-26 2022-02-08 Washington University Methods for modulation of dietary and microbial exposure with compositions comprising an EGFR ligand
CN113813369B (zh) * 2021-11-09 2023-09-22 浙江省农业科学院 用于预防/治疗仔猪肠道损伤的egf/mmt复合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8409960D0 (en) * 1984-04-17 1984-05-31 Searle & Co Therapeutic method
EP0292517B1 (en) * 1986-12-11 1992-09-09 Btg International Limited Improvements in or relating to the use of epidermal growth factor
ATE161181T1 (de) 1992-07-06 1998-01-15 Nestle Sa Lactobacillus acidophilus enthaltende antigastritis-mittel
US5753622A (en) * 1995-05-10 1998-05-19 University Technologies International, Inc. Use of epidermal growth factor as a gastrointestinal therapeutic agent

Also Published As

Publication number Publication date
US6656907B1 (en) 2003-12-02
AU704675B2 (en) 1999-04-29
AU5641196A (en) 1996-11-29
DK1092437T3 (da) 2005-01-31
DE69633583T2 (de) 2006-02-23
HK1072894A1 (en) 2005-09-16
CA2220434C (en) 2005-02-22
CA2492724C (en) 2010-08-03
ATE278415T1 (de) 2004-10-15
CA2220434A1 (en) 1996-11-14
ES2285320T3 (es) 2007-11-16
DE69614377D1 (de) 2001-09-13
DE69614377T2 (de) 2002-05-23
EP1092437B1 (en) 2004-10-06
EP0824357A1 (en) 1998-02-25
US5753622A (en) 1998-05-19
DE69633583D1 (de) 2004-11-11
CA2492724A1 (en) 1996-11-14
DK0824357T3 (da) 2001-10-08
WO1996035445A1 (en) 1996-11-14
EP0824357B1 (en) 2001-08-08
PT1479394E (pt) 2007-04-30
NZ501482A (en) 2004-12-24
DE69637002D1 (de) 2007-05-10
ATE357927T1 (de) 2007-04-15
DE69637002T2 (de) 2007-08-16
ES2226681T3 (es) 2005-04-01
JP3549541B2 (ja) 2004-08-04
ATE203912T1 (de) 2001-08-15
EP1092437A1 (en) 2001-04-18
JPH11505528A (ja) 1999-05-21
NZ307134A (en) 2000-02-28
EP1479394A1 (en) 2004-11-24
EP1479394B1 (en) 2007-03-28

Similar Documents

Publication Publication Date Title
DK1479394T3 (da) Anvendelse af epidermal vækstfaktor (EGF) til ögning af vækstforögelse hos et dyr
ATE95060T1 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzuendlicher und viraler hauterkrankungen.
NO933525D0 (no) Xylanase, tilsvarende rekombinant dna-sekvens, xylanaseholding middel og anvendelse av middelet
MD1632F2 (en) Bicyclic compounds, method of inhibiting the tyrosine kinases receptors as epidermal growth factor, pharmaceutical composition, methods of preventing blastocyte implantation and treatment of mammals
AU2118488A (en) Improvements in or relating to methods of treating damaged skin
ATE184289T1 (de) Ribosomen-inaktivierende proteine, inaktive vorläuferformen derselben, verfahren zur herstellung und eine methode zur nutzung
ATE225176T1 (de) Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie
DE3586346D1 (de) Mikrobielle herstellung von propionsaeure in mischkultur.
AU1878197A (en) Agents and processes for the production of aquarial and garden pond water
ATE158183T1 (de) Arzneimittel zur behandlung von anxietas
DE69001573D1 (de) Zusammensetzungen zur herstellung von in dosisformen aktiven vitaminen d3 sowie verfahren zur herstellung stabiler, in dosisformen aktiver vitamine d3 unter deren verwendung.
YU78092A (sh) Postupak za dobijanje derivata beta-fenilizoserina i njihova primena
ATE178206T1 (de) Verfahren zur vorbeugung und behandlung von durch chemotherapie ausgelöster alopezie
ATE47274T1 (de) Tierstreu sowie verfahren zur herstellung derselben.
DE68903907D1 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
DE59006307D1 (de) Badezusatz und dessen Verwendung.
ATE234613T1 (de) Verwendung von comt inhibitoren zur herstellung eines arzneimittels zur vorbeugung von diabetischen vaskulären funktionsstörungen
DE68914660D1 (de) Verfahren zur Herstellung von den Safranblütennarben ähnlichem Gewebe sowie Verfahren zur Herstellung von nützlichen Stoffen aus safranblütennarbenähnlichem Gewebe.
JPS5729270A (en) Preparation of nonheat-coagulable egg white
ATE84295T1 (de) Verfahren zur herstellung von 2,6,6-trimethylcyclohex-2-en-1,4-dion.
IL107242A0 (en) Derivatives of benzeneborinic acid, preparation thereof and use thereof as synthetic intermediates
MY108436A (en) Feed and method for promoting or improving the growth of animals
AU2719488A (en) Method for supplying an oblong plant trough with end walls and apparatus for carrying out the method
BG60542B2 (en) Water soluble composition having coccidiostatic effect